Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 10 pseudogene 1 is a processed or duplicated segment of DNA highly homologous to the SEPTIN10 gene but does not encode a functional cytoskeletal protein. Human pseudogenes like SEPTIN10P1 generally do not produce active proteins but may have roles in regulatory networks, typically as noncoding RNAs that can influence the expression of their parent genes through mechanisms such as competing endogenous RNA activity or miRNA sponging[7][3][5][1]. Although pseudogenes are increasingly recognized for regulatory potential and possible contributions to disease processes, SEPTIN10P1 itself is not an established drug target, does not encode a protein, and has no reported direct role in signal transduction or specific disease phenotypes; its entry as a target is likely incorrect. If you seek a canonical target involving septins, the functional gene is Septin 10 (SEPTIN10), a cytoskeletal GTPase involved in cytokinesis and microtubule stability[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 10 pseudogene 1 (SEPTIN10P1).